| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MYBPC3:Arg1002Gln | FS | M | 60-69 | I | 28 | 54 | 38 | Elderly FH | |||||
| MYBPC3:Arg326Gln | BN | F | 40-49 | 60-69 | II | 20 | 42 | 50 | 60 | HCM | |||
| MYBPC3:Arg326Gln | FSB | F | 60-69 | 80-89 | II | 32 | 39 | Elderly HC | |||||
| MYBPC3:Arg495Gln | DQ | M | 70 | 149 | 10-19 | 18 | 42 | 25 | 34 | 78 | HCM | ||
| MYBPC3:Arg495Gln | DQ | F | 64 | 163 | 40-49 | 12 | 40 | 22 | 30 | 60 | HCM | ||
| MYBPC3:Arg495Gln | DQ | F | 40-49 | 32 | 31 | 21 | 38 | 55 | HCM | ||||
| MYBPC3:Arg495Gln | DQ | M | 68 | 160 | 70-79 | 30 | 40 | 26 | 42 | 55 | HCM | ||
| MYBPC3:Arg502Trp | FU | M | 169 | 60-69 | 17 | 52 | 31 | 46 | 55 | HCM | |||
| MYBPC3:Glu1017Lys | SS-203 | M | 70 | 173 | 10-19 | 30-39 | 20 | 65 | 48 | 47 | 65 | HCM | |
| MYBPC3:Glu451Gln | DI | M | 30-39 | I | 25 | 39 | |||||||
| MYBPC3:Glu451Gln | DI | M | 30-39 | I | 13 | 38 | |||||||
| MYBPC3:Glu451Gln | DI | M | 30-39 | I | 17 | 29 | |||||||
| MYBPC3:Glu451Gln | DI | F | 50-59 | IV | 15 | 52 | |||||||
| MYBPC3:Glu451Gln | DI | M | 60-69 | II | 26 | 46 | |||||||
| MYBPC3:Glu451Gln | DI | M | 40-49 | I | 25 | 49 | |||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYBPC3:Glu451Gln | DI | M | 40-49 | IV | 17 | 49 | |||||||
| MYBPC3:Glu451Gln | DI | F | 50-59 | I | 35 | 35 | |||||||
| MYBPC3:Glu451Gln | DI | F | 20-29 | II | 27 | 37 | |||||||
| MYBPC3:Glu451Gln | P | M | 16 | 39 | 24 | 38 | 77 | HCM | |||||
| MYBPC3:Glu451Gln | P | F | 44 | 27 | 32 | HCM | |||||||
| MYBPC3:Glu451Gln | P | M | 21 | 46 | HCM | ||||||||
| MYBPC3:Glu451Gln | P | F | 14 | 35 | HCM | ||||||||
| MYBPC3:Glu451Gln | P | M | 26 | 46 | HCM | ||||||||
| MYBPC3:Glu451Gln | P | F | 31 | 41 | HCM | ||||||||
| MYBPC3:Glu451Gln | P | M | 23 | 39 | HCM | ||||||||
| MYBPC3:Glu451Gln | P | M | 38 | HCM | |||||||||
| MYBPC3:Gly1248_Cys1253dup | GL | F | 63 | 176 | 40-49 | 23 | 42 | 21 | 41 | 60 | HCM | ||
| MYBPC3:Gly263Arg | HO | M | 223 | 70-79 | II | 17 | 53 | 38 | 45 | 75 | HCM | ||
| MYBPC3:IVS18+4A>T | FQ | F | 64 | 146 | 30-39 | 26 | 43 | 23 | 38 | 55 | HCM | ||
| MYBPC3:IVS24+1G>A | BO | F | 133 | 80-89 | 22 | 34 | 20 | 41 | HCM | ||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYBPC3:IVS24+1G>A | BO | F | 50 | 10-19 | 10 | 38 | 20 | 25 | HCM | ||||
| MYBPC3:IVS24+1G>A | BO | M | 66 | 160 | 40-49 | 15 | 45 | 22 | 36 | HCM | |||
| MYBPC3:IVS24+1G>A | BO | F | 62 | 133 | 70-79 | 20 | 35 | 16 | 47 | 55 | HCM | ||
| MYBPC3:IVS24+1G>A | BO | F | 61 | 80-89 | 20 | 32 | 17 | 40 | 47 | HCM | |||
| MYBPC3:IVS24+1G>A | BO | M | 74 | 174 | 40-49 | 10 | 44 | 24 | 35 | HCM | |||
| MYBPC3:IVS27-3C>G | SS-170 | M | 76 | 270 | 50-59 | I | 14 | 40 | 24 | 48 | 65 | HCM | |
| MYBPC3:Leu901fs | IT | F | 67 | 134 | 10-19 | 10-19 | 15 | 40 | 19 | 41 | 65 | HCM | |
| MYBPC3:Lys1065fs | IQ | M | 74 | 220 | 10-19 | 50-59 | 13 | 77 | 64 | 44 | 15 | HCM | |
| MYBPC3:Thr59Ala | FSL | M | 70-79 | 90-99 | II | 23 | 52 | elderly FH | |||||
| MYBPC3:Trp792fs | BW | M | 72 | 230 | 40-49 | 18 | 47 | 26 | 42 | 60 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 70 | 270 | 30-39 | 18 | 48 | 24 | 44 | 60 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 72 | 215 | 30-39 | 18 | 46 | 26 | 31 | 60 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 67 | 160 | 30-39 | 11 | 46 | 23 | 34 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 68 | 197 | 50-59 | 16 | 39 | 23 | 36 | HCM | |||
| MYBPC3:Trp792fs | BW | M | 60-69 | 20 | 41 | 43 | HCM | ||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYBPC3:Trp792fs | BW | F | 61 | 155 | 50-59 | 17 | 43 | 22 | 35 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 69 | 186 | 40-49 | 17 | 47 | 19 | 41 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 68 | 189 | 40-49 | 13 | 44 | 24 | 41 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 64 | 140 | 60-69 | 10 | 40 | 23 | 30 | 79 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 63 | 191 | 40-49 | 18 | 41 | 30 | 32 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 40-49 | 10 | 48 | 26 | 37 | 65 | HCM | ||||
| MYBPC3:Trp792fs | BW | M | 70 | 184 | 30-39 | 13 | 51 | 32 | 36 | 70 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 63 | 140 | 60-69 | 25 | 41 | 27 | 50 | 70 | HCM | ||
| MYBPC3:Trp792fs | BW | F | 187 | 70-79 | 20 | 47 | 40 | 68 | 64 | HCM | |||
| MYBPC3:Trp792fs | BW | F | 62 | 150 | 30-39 | 16 | 38 | 16 | 33 | 65 | HCM | ||
| MYBPC3:Trp792fs | BW | M | 194 | 40-49 | 20 | 47 | 39 | 44 | 60 | HCM | |||
| MYBPC3:Val671fs | FU | 70 | 189 | 30-39 | 28 | 45 | 25 | 37 | HCM | ||||
| MYBPC3:Val671fs | HE | F | 167 | 30-39 | 10.5 | 48.3 | 36 | HCM | |||||
| MYBPC3:Val753fs | HI | M | 74 | 165 | 30-39 | 30-39 | 22 | 40 | 55 | HCM | |||
| MYBPC3:Val896Met | IF | M | 12 | 52 | 25 | 45 | |||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYBPC3:Val896Met | IF | M | 269 | 40-49 | 18 | 55 | 36 | 60 | HCM | ||||
| MYH7:Ala355Thr | EC | M | 195 | 50-59 | II | 17 | 45 | 31 | 77 | 65 | HCM | ||
| MYH7:Ala742Glu | SS-244 | F | 40-49 | 16 | HCM | ||||||||
| MYH7:Arg249Gln | 70 | 210 | 20-29 | 40-49 | 19 | 45 | 31 | 54 | 68 | HCM | |||
| MYH7:Arg403Gln | C | F | 20-29 | II | 17 | 41 | |||||||
| MYH7:Arg403Gln | C | F | 20-29 | II | 12 | 35 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | III | 20 | 45 | |||||||
| MYH7:Arg403Gln | C | M | 30-39 | III | 10 | 49 | |||||||
| MYH7:Arg403Gln | C | F | 20-29 | II | 21 | 39 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | II | 25 | 45 | |||||||
| MYH7:Arg403Gln | C | M | 20-29 | II | 30 | 40 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | III | 20 | 45 | |||||||
| MYH7:Arg403Gln | C | M | 20-29 | II | 28 | 34 | |||||||
| MYH7:Arg403Gln | C | M | 40-49 | I | 19 | 52 | |||||||
| MYH7:Arg403Gln | C | M | 30-39 | III | 10 | 49 | |||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Arg403Gln | C | F | 40-49 | II | 25 | 45 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | II | 20 | 45 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | II | 22 | 45 | |||||||
| MYH7:Arg403Gln | C | F | 40-49 | II | 15 | 37 | |||||||
| MYH7:Arg403Gln | C | F | 20-29 | I | 34 | 55 | |||||||
| MYH7:Arg403Gln | C | M | 20-29 | I | 30 | 49 | |||||||
| MYH7:Arg403Gln | C | M | 20-29 | IV | 22 | 65 | |||||||
| MYH7:Arg403Gln | C | M | 10-19 | II | 28 | 40 | |||||||
| MYH7:Arg403Gln | C | F | 20-29 | II | 16 | 47 | |||||||
| MYH7:Arg403Gln | C | M | 10-19 | II | 18 | 44 | |||||||
| MYH7:Arg403Gln | C | F | 20-29 | II | 22 | 39 | |||||||
| MYH7:Arg403Gln | C | M | 20-29 | I | 28 | 41 | |||||||
| MYH7:Arg403Gln | EH | F | 61 | 100 | 70-79 | 53 | 40 | 70 | 40 | HCM | |||
| MYH7:Arg403Trp | SS-192 | F | 30-39 | 12 | 40 | 20 | 25 | HCM | |||||
| MYH7:Arg442His | MEB | M | 0-9 | 30-39 | 9 | 73 | 58 | 43 | DCM/fibroelastosis | ||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Arg652Gly | CP | M | 68 | 165 | 20-29 | 20-29 | 16 | 38 | 20 | 55 | 65 | HCM | |
| MYH7:Arg652Gly | CP | 10-19 | 10 | 48 | 32 | HCM | |||||||
| MYH7:Arg652Gly | CP | 20-29 | 20-29 | 11 | 52 | 34 | 30 | 63 | HCM | ||||
| MYH7:Arg663His | CG | F | 50-59 | 20 | 45 | 18 | 44 | 76 | HCM | ||||
| MYH7:Arg663His | CG | M | 70-79 | 38 | 27 | 52 | HCM | ||||||
| MYH7:Arg663His | CG | M | 30-39 | 50 | 37 | 63 | 20 | HCM | |||||
| MYH7:Arg663His | CG | F | 50-59 | 43 | 26 | 35 | HCM | ||||||
| MYH7:Arg663His | CG | F | 20-29 | 10.1 | 40 | 24 | 36 | 83 | HCM | ||||
| MYH7:Arg663His | CG | M | 40-49 | 52 | 36 | 44 | HCM | ||||||
| MYH7:Arg663His | CG | F | 47 | 28 | 46 | HCM | |||||||
| MYH7:Arg663His | CG | M | 0-9 | 28 | 17 | 23 | HCM | ||||||
| MYH7:Arg663His | CG | F | 41 | 22 | 32 | HCM | |||||||
| MYH7:Arg663His | CG | F | 69 | 212 | 20-29 | 28.6 | 46 | 24 | 51 | 75 | HCM | ||
| MYH7:Arg663His | CG | F | 70-79 | 38 | 21 | 36 | HCM | ||||||
| MYH7:Arg663His | CG | F | 30-39 | 46 | 28 | 31 | HCM | ||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Arg663His | CG | M | 51 | 34 | 43 | HCM | |||||||
| MYH7:Arg663His | CG | F | 62 | 146 | 50-59 | 21.8 | 42 | 21 | 47 | 75 | HCM | ||
| MYH7:Arg663His | SS-248 | F | 30-39 | 16 | 40 | 17 | 49 | 75 | HCM | ||||
| MYH7:Arg663His | SS-265 | M | 50-59 | 27 | HCM | ||||||||
| MYH7:Arg663His | SS-272 | F | 62 | 175 | 40-49 | 50-59 | 15 | 37 | 22 | 37 | 70 | HCM | |
| MYH7:Arg663His | SS-283 | M | 30-39 | 28 | HCM | ||||||||
| MYH7:Arg719Gln | SS-234 | F | 30-39 | 17 | HCM | ||||||||
| MYH7:Arg723Cys | SS-271 | M | 40-49 | 27 | HCM | ||||||||
| MYH7:Arg870Cys | FT | M | 75 | 206 | 10-19 | 30-39 | III | 51 | 32 | 45 | 70 | HCM | |
| MYH7:Arg870Leu | GO | 19 | 39 | 17 | 46 | 75 | HCM | ||||||
| MYH7:Arg870Leu | GO | 23 | 41 | 19 | 31 | 75 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 68 | 224 | 40-49 | 13.8 | 44 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 72 | 160 | 30-39 | 17.2 | 47 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 0-9 | 6.3 | 32 | HCM | ||||||||
| MYH7:Asp906Gly | EJ | 67 | 215 | 40-49 | 15 | 43 | HCM | ||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Asp906Gly | EJ | 70 | 160 | 20-29 | 11.3 | 45 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 65 | 125 | 20-29 | 9.3 | 41 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 64 | 189 | 50-59 | 19.9 | 42 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 69 | 155 | 20-29 | 15.7 | 40 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 68 | 170 | 30-39 | 11.7 | 45 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 67 | 130 | 10-19 | 8.6 | 46 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 72 | 200 | 30-39 | 10.6 | 50 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 65 | 120 | 20-29 | 9.8 | 39 | HCM | ||||||
| MYH7:Asp906Gly | EJ | M | 70 | 160 | 10-19 | 20-29 | II | 23 | 40 | 24 | 38 | HCM | |
| MYH7:Asp906Gly | EJ | 70 | 200 | 30-39 | 9.5 | 51 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 66 | 130 | 50-59 | 13 | 45 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 69 | 185 | 20-29 | 11.2 | 47 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 67 | 180 | 30-39 | 10.5 | 45 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 63 | 110 | 10-19 | 8.9 | 45 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 65 | 175 | 12.1 | 46 | HCM | |||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Asp906Gly | EJ | 71 | 170 | 40-49 | 8.8 | 49 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 72 | 225 | 40-49 | 15.4 | 47 | HCM | ||||||
| MYH7:Asp906Gly | EJ | 68 | 176 | 30-39 | 8.6 | 52 | HCM | ||||||
| MYH7:Glu846Lys | SS-227 | F | 67.5 | 135 | 20-29 | 30-39 | 14 | 48 | 25 | 44 | 70 | HCM | |
| MYH7:Gly1101Ser | SS-172 | M | 24 | HCM | |||||||||
| MYH7:Gly768Arg | BX | M | 14.3 | 43 | 23 | 42 | 73 | HCM | |||||
| MYH7:Gly768Arg | BX | F | 30-39 | 42 | 28 | 38 | HCM | ||||||
| MYH7:His576Arg | EW | M | 174 | 40-49 | 14 | 50 | 22 | 44 | HCM | ||||
| MYH7:Ile736Thr | SS-278 | M | 50-59 | 16 | HCM | ||||||||
| MYH7:Ile736Val | SS-191 | F | 110 | 40-49 | 20 | 36 | 22 | 46 | 65 | HCM | |||
| MYH7:Leu908Val | HG | F | 214 | 30-39 | 40-49 | II | 47 | 30 | 68 | 55 | HCM | ||
| MYH7:Phe764Leu | MAI | 10-19 | II | 39 | DCM | ||||||||
| MYH7:Phe764Leu | MAI | 40-49 | III | 67 | 62 | DCM | |||||||
| MYH7:Ser532Pro | M | 40-49 | III | 61 | 50 | DCM | |||||||
| MYH7:Ser532Pro | M | I | 56 | 45 | DCM | ||||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Ser532Pro | M | 10-19 | I | 55 | 41 | DCM | |||||||
| MYH7:Ser532Pro | M | 20-29 | II | 59 | 42 | DCM | |||||||
| MYH7:Ser532Pro | M | 10-19 | I | 54 | 40 | DCM | |||||||
| MYH7:Ser532Pro | M | I | 53 | 36 | DCM | ||||||||
| MYH7:Ser532Pro | M | 70-79 | II | 58 | 42 | DCM | |||||||
| MYH7:Ser532Pro | M | 40-49 | I | 52 | 41 | DCM | |||||||
| MYH7:Ser532Pro | M | 60-69 | IV | 61 | 55 | DCM | |||||||
| MYH7:Ser532Pro | M | 30-39 | 85 | 75 | 25 | DCM | |||||||
| MYH7:Ser532Pro | M | 60-69 | II | 51 | 44 | DCM | |||||||
| MYH7:Ser532Pro | M | 60-69 | II | 70 | 60 | DCM | |||||||
| MYH7:Ser532Pro | M | 20-29 | I | 50 | 36 | DCM | |||||||
| MYH7:Ser532Pro | M | 50-59 | II | 51 | 33 | DCM | |||||||
| MYH7:Ser532Pro | M | 50-59 | II | 58 | 44 | DCM | |||||||
| MYH7:Ser532Pro | M | 40-49 | IV | 78 | 68 | DCM | |||||||
| MYH7:Ser532Pro | M | 0-9 | II-III | 5.8 | 39 | 28 | DCM | ||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| MYH7:Ser532Pro | M | 30-39 | IV | 90 | 76 | DCM | |||||||
| MYH7:Ser532Pro | M | 40-49 | III | 61 | 48 | DCM | |||||||
| MYH7:Val39Met | SS-199 | M | 69 | 175 | 40-49 | 40-49 | 12 | 54 | 32 | 42 | 71 | HCM | |
| MYH7:Val606Met | SS-259 | M | 10-19 | 37 | HCM | ||||||||
| MYH7:Val698Ala | SS-255 | M | 30-39 | 28 | HCM | ||||||||
| MYL2:Asn47Lys | IE | M | 14 | 48 | 33 | 70 | HCM | ||||||
| TNNI3:Arg204Cys | HN | M | 10-19 | 10-19 | 59 | 46.7 | 33.7 | 38 | HCM | ||||
| TNNI3:Ile195Met | IH | 70 | 135 | 30-39 | 50-59 | IIII | 9 | 42 | 22 | 54 | 50 | HCM | |
| TNNI3:Ile195Met | IH | 73 | 140 | 20-29 | 20-29 | 7 | 42 | 28 | 46 | HCM | |||
| TNNT2:Arg278Cys | SS-206 | 69.5 | 218 | 33 | 51 | 28 | 53 | 75 | HCM | ||||
| TNNT2:Arg278Cys | SS-268 | F | 30-39 | 32 | HCM | ||||||||
| TNNT2:Arg278Cys | SS-298 | F | 66 | 135 | 30-39 | 30-39 | 19 | 43 | 28 | 29 | 65 | HCM | |
| TNNT2:Lys210del | MAH | F | 50-59 | 51 | 35 | 29 | DCM | ||||||
| TNNT2:Lys210del | MDI | M | 50-59 | III | 74 | 70 | DCM | ||||||
| TNNT2:Lys210del | MDI | F | 30-39 | II | 68 | 59 | DCM | ||||||
| mutation | pedigree | sex | height (in.) | weight (lb.) | age of onset | age at exam | NYHA Class | LVWT, mm. | LVED | LVES | LA | EF, % | diagnosis |
| TNNT2:Lys210del | MDI | F | 60-69 | III | 63 | 55 | DCM | ||||||
| TNNT2:Lys97Asn | FK | F | 66 | 165 | 10-19 | 30-39 | I | 50 | 30 | 50 | 50 | HCM | |
| TPM1:Glu192Lys | CHL | F | 68 | 129 | 20-29 | 21 | 44.4 | 17.6 | 31 | 65 | ASD/HCM | ||
| TPM1:Val95Ala | GR | M | 73 | 210 | 30-39 | 15 | 50 | 37 | 29 | 62 | HCM |
Last modified: February 17, 2004